Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
10.74
+0.37 (3.57%)
At close: Aug 3, 2026, 4:00 PM EDT
10.74
0.00 (0.00%)
After-hours: Aug 3, 2026, 4:20 PM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $154.9 million as of August 3, 2026. Its market cap has increased by 19.10% in one year.
Market Cap
154.90M
Enterprise Value
41.16M
1-Year Change
19.10%
Ranking
Category
Stock Price
$10.74
ChartMarket Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $154.90M, an increase of 25.12%. That is a compound annual growth rate of 8.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 154.90M | 105.35% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 154.38M |
| OnKure Therapeutics | 154.31M |
| YD Bio | 152.59M |
| Milestone Pharmaceuticals | 151.02M |
| Nkarta | 149.53M |
| Canton Strategic Holdings | 148.85M |
| Entera Bio | 147.38M |
| Cibus | 147.32M |